Adverum Biotechnologies Stock (NASDAQ: ADVM) stock price, news, charts, stock research, profile.
Open | $7.05 |
Close | $7.32 |
Volume / Avg. | 114.36K / 333.09K |
Day Range | $7.01 - $7.37 |
52 Wk Range | 6.38 - 29.70 |
Market Cap | $152.26M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 6.1% |
Days to Cover | 2.25 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Adverum Biotechnologies (NASDAQ:ADVM) through any online brokerage.
Other companies in Adverum Biotechnologies’s space includes: Skye Bioscience (NASDAQ:SKYE), Galectin Therapeutics (NASDAQ:GALT), bluebird bio (NASDAQ:BLUE), Adicet Bio (NASDAQ:ACET) and aTyr Pharma (NASDAQ:ATYR).
Adverum Biotechnologies has a consensus price target of $24.43.
The stock price for Adverum Biotechnologies (NASDAQ: ADVM) is $7.32 last updated August 23, 2024 at 4:37 PM EDT.
There are no upcoming dividends for Adverum Biotechnologies.
Adverum Biotechnologies’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Adverum Biotechnologies.
Adverum Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.